British American Tobacco Share Discussion Threads

[philanderer] 12/11/2018 14:50

CC , luck with those. I added 10% more @ 2995p

[minerve] 12/11/2018 14:30

Income play.

[minerve] 12/11/2018 14:30

Doubled my holding.

[creditcrunchies] 12/11/2018 14:29

Bought some at around 2990 not sure just when the crash in share price will stop though

[creditcrunchies] 12/11/2018 14:20

It's difficult to BATS to comment on their share price crashing because the CEO is in all fours puking in the can

[creditcrunchies] 12/11/2018 14:17

Yeah let's see how many $billion get wiped off at the US. This is like an AIM stock with moves like this

[essentialinvestor] 12/11/2018 14:12

Action, you tempted?.

[philanderer] 12/11/2018 14:11

Difficult for BATS to comment on the share price fall while these news reports do not yet contain an official release from the FDA.

[action] 12/11/2018 14:00

capitulation is not done yet. wait for USA open.

[philanderer] 12/11/2018 14:00

Analysts call menthol selloff overblown

Nov. 12, 2018 8:36 AM ET|By: Clark Schultz, SA News Editor

Several investment firms are in with recommendations to buy the menthol dip.

For starters, Height Capital Markets analyst doesn't expect any "meaningful" regulatory action from the FDA on menthol. The firm reminds that even if legislation is worked out before 2022, the tobacco industry will fire off litigation to slow the process.

Wells Fargo analyst Bonnie Herzog also recommends buying into the share price weakness on the menthol news. "We don’t believe the science supports the assertion that menthol cigs are more harmful than non-menthol; this alone would make banning menthol difficult," she writes to clients.

[philanderer] 12/11/2018 13:48

Indeed CC , fe%&in nightmare this one. Bad day for the portfolio even without this one , just 2/21 blue :-S

[creditcrunchies] 12/11/2018 13:43

Bats share price this year is the largest drop in % terms in the past 20 years even worse than the drop in the financial crisis. Apparently.

[this_time_its_different] 12/11/2018 13:42

BE GREEDY WHEN OTHERS ARE FEARFUL

[this_time_its_different] 12/11/2018 11:57

Bargain price, FDA is bluffing. 7% growing yield, load up boys.

[gutterhead] 12/11/2018 11:49

almost 7% yield at this price.

[essentialinvestor] 12/11/2018 11:47

As I mentioned previously, what the Reynolds acquisition resulted in
was the cancellation of accretive buy backs, and a very significant amount
of extra debt. From memory BATS had something in the region of £13/14 Billion?
net debt before their acquisition spree, it's now well in excess of £40 Billion.

[zho] 12/11/2018 11:30

Discussed at

[lurker] 12/11/2018 11:29

Well I have bought today...these looked good value at £40...and essentially from a financial perspective in terms of p/e and dividend yield. Nothing at all has changed today.

Sometimes the market just gives you a bargain...like Shell at £15 and BT at around £2...Fear and Greed!

[minerve] 12/11/2018 11:27

" Also many users would switch back to non-menthol rather than quitting."

Which is what I said earlier. It isn't rocket science.

[philanderer] 12/11/2018 11:19

Paraphrased from the FT:

Jefferies analyst Owen Bennett says any ban would hit Juul the hardest allowing big companies to take back market share. Also many users would switch back to non-menthol rather than quitting.

An outright ban on menthol cigarettes is not likely to be passed by the courts. BATS fall is overdone.

[minerve] 12/11/2018 10:58

sauron 12 Nov '18 - 10:21 - 2017 of 2020

"Previous CEO got BAT out of the US market. This fool reversed that despite knowing that the FDA is unpredictable"

US divisions vs ROW separated to limit litigation liabilities when they were rife - it wasn't to avoid the FDA. Litigation has cooled off (on the old products) because smokers now know the risks - in developed countries anyway.

The tobacco industry is one of consolidation and companies have to consolidate through M&A or they may found themselves without a seat when the music stops.

[this_time_its_different] 12/11/2018 10:39

FDA is bluffing, VERY STRONG BUY

[philanderer] 12/11/2018 10:31

Up in smoke? BAT sinks on possible menthol ban

Nov. 12, 2018 5:05 AM ET|By: Yoel Minkoff, SA News Editor

The last ten years it was clove cigarettes, but this decade may see a menthol ban.

Following a 4% fall on Friday, British American Tobacco (NYSEMKT:BTI) shares are down almost 7% premarket on news that the FDA may take the minty product off the market.

"BAT is the most exposed name to the potential risk," wrote Morgan Stanley's Richard Taylor, who estimates that U.S. menthol cigarettes (and its Newport brand) account for 25% of total earnings.

[sauron] 12/11/2018 10:21

Previous CEO got BAT out of the US market. This fool reversed that despite knowing that the FDA is unpredictable